Key result
hs-cTnI yields comparable diagnostic accuracy to hs-cTnT for AMI but has inferior prognostic value.
Why the study?
Does hs-cTnI compared to hs-cTnT improve diagnostic accuracy for acute myocardial infarction and prognostic accuracy for all-cause mortality in patients presenting to the emergency department with acute chest pain?
Observational (n=2,211)
Yes
Does hs-cTnI compared to hs-cTnT improve diagnostic accuracy for acute myocardial infarction and prognostic accuracy for all-cause mortality in patients presenting to the emergency department with acute chest pain?
In patients presenting with acute chest pain, hs-cTnI offers superior diagnostic accuracy for early AMI, whereas hs-cTnT provides superior prognostic accuracy for all-cause mortality.
Answers are grounded in this paper and cite their sources.
May not yet guide troponin assay selection in ED chest pain; leaves open need for randomized outcome trials.
Purpose: The aim of our study was to compare the accuracy of high-sensitivity cardiac troponins (hs-cTn) I and T in the early diagnosis of acute myocardial infarction, as well as their utility to predict all-cause mortality.Methods: In a prospective multicenter study we measured 2 different hs-cTn assays (hs-cTnI Abbott) and hs-cTnT Roche) and compared their diagnostic and prognostic accuracies in consecutive patients presenting to the emergency department (ED) with acute chest pain.The final diagnosis of AMI was adjudicated by two independent cardiologists using all information pertaining to the individual patient including serial measurements of hs-cTnT.Mean follow up (FU) was 24 months.Results: Among 2211 consecutive patients, 21% had an adjudicated final diagnosis of AMI.The diagnostic accuracy as quantified by the area under the receiveroperating-characteristics curve (AUC) was slightly higher with the hs-cTnI assay (AUC 0.93; 95% confidence interval (CI) 0.92-0.94)than with the hs-cTnT (AUC 0.92; 95% CI 0.91-0.93;p = 0.078).In early presenters (<3h since chest pain onset) this difference (AUC for hs-cTnI 0.93; 95% CI 0.90-0.95;AUC for hs-cTnT 0.87; 95% CI 0.83-0.89)was much larger and highly statistically significant (p<0.001).The prognostic accuracy for all-cause mortality during FU, quantified by AUC, was significantly higher for hs-cTnT (AUC 0.79; 95% CI 0.78-0.81)as compared to hs-cTnI (AUC 0.76; 95% CI 0.74-0.77)p<0.001.Conclusion: Both hs-cTnI and hs-cTnT provide high diagnostic and prognostic accuracy.
No takes yet. Share an insight, caveat, or question.
A 2013 study conducted an observational in acute chest pain (n=2,211). hs-cTnI (Abbott) vs. hs-cTnT (Roche) was evaluated on diagnostic accuracy for acute myocardial infarction (AUC) (p=0.078). High-sensitivity cardiac troponin I had slightly higher diagnostic accuracy for acute myocardial infarction than hs-cTnT, while hs-cTnT had superior prognostic accuracy.
Synapse has enriched 10 related papers. Consider them for comparative context: